Betrecep 5 Mg (Tofacitinib)

What Is Betrecep 5 Mg? 

Betrecep 5 Mg (Tofacitinib) is a TGA-approved drug used to treat certain inflammatory conditions that contains the active ingredient, tofacitinib. It is produced by Pfizer India Ltd and part of a class of drugs known as Janus kinase (JAK) inhibitors. These drugs are used to regulate excessive immune system responses that lead to inflammation. Betrecep 5 Mg comes as film-coated tablets, usually supplied in blister packs. This medicine should only be taken after consulting your GP or rheumatologist.

Uses of Betrecep 5 Mg

Rheumatoid arthritis

This is a long-term autoimmune disorder in which the immune system mistakenly attacks the joints. This results in swelling, stiffness, and eventual joint damage. Betrecep 5 Mg Tablet is prescribed to treat moderate to severe active rheumatoid arthritis in adults who don’t get enough pain relief on other treatments or who can’t tolerate them.  

Decrease pain

Doctors are aware that joint pain is a very important symptom of active RA. Betrecep tablet is indicated in the treatment of this pain as part of a complete treatment of the disease.

Tenderness 

Joint tenderness means that an inflamed (swollen) joint will feel tender (sensitive) to the touch and/or pressure. Betrecep 5 mg tablet uses include helping to lessen this tenderness.

How Betrecep 5 Mg Works  

Tofacitinib 5 mg is a medicine that interferes with the action of a type of enzyme found in cells that is called Janus kinase. Normally, these enzymes transmit signals that trigger inflammation. The medicine decreases the production of inflammatory messengers by decreasing the activity of JAK. This reduces the swelling of the joints and the rate of cartilage and bone destruction.  

Benefit of Betrecep 5 Mg  

Physical benefits  

• reduced joint swelling  
• less joint tenderness  
• lower daily pain  
• better joint movement  

Psychological benefits  

• less worry about flares  
• greater confidence in daily tasks  
• improved sense of symptom control  

Dosage and Administration  

The Betrecep 5 Mg dosage is determined by your rheumatologist. The typical recommended adult dose is one 5-mg tablet taken two times a day, before or after meals. Administer at regular intervals throughout the day. Take a missed dose as soon as remembered unless it is time for the next dose. Do NOT double the dose! Take as prescribed and directed by your pharmacist. 

Side Effects of Betrecep 5 Mg  

Common Betrecep side effects include:  

• upper respiratory tract infection  
• headache  
• diarrhoea  
• nasopharyngitis  
• nausea  

Drug Interactions  

• ketoconazole  
• fluconazole  
• rifampicin  
• other strong CYP3A4 inhibitors or inducers  
• live vaccines  

Inform your doctor and pharmacist of all the medicines and supplements you take. 

Important Safety Warnings  

This medicine increases the risk of serious infections such as TB and shingles. Before commencing, tests are required to check for dormant TB. It could also raise the risk of blood clots, serious heart events, and some types of cancer. Regular blood tests include monitoring blood counts, liver function, and cholesterol. Avoid live vaccines. See your GP or specialist as soon as you notice any new symptoms. 

Who Should Avoid Betrecep 5 Mg?  

Avoid this medicine if you have an active serious infection, an allergy to tofacitinib, or severe liver impairment. Not recommended during pregnancy and lactation. Effective contraception should be used during treatment for women of childbearing potential. Careful risk assessment is important for people over the age of 65 or those with heart disease, had clots in the past, or cancer.  

Storage and Handling  

• Store below 30 °C in original packaging  
• Protect from moisture  
• Keep out of reach of children  
• Do not use after the expiry date  
• Return unused tablets to a pharmacy for disposal  

Tips for Safe and Effective Use  

• Take tablets at the same times daily  
• Attend all blood tests and reviews  
• Tell every health professional you take this medicine  
• Practise good hygiene and avoid contagious contacts  
• Report infection signs early  
• Do not stop or change the dose without advice 

Conclusion  

Betrecep 5 Mg (Tofacitinib) is used to treat moderate to severe rheumatoid arthritis, when other drugs have not worked well enough, to help control the disease and to help prevent it getting worse. It is only used under specialist care with regular monitoring, as part of a plan. Take your rheumatologist’s advice and consult your GP or pharmacist if you have any concerns. Additional details at GenericMedsAustralia.com.  

FAQs